BlackRock »

Gain Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $151k 85k 1.78

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Gain Therapeutics

DME Capital Management
Gotham Asset Management
Geode Capital Management
Vanguard Group
Cable Car Capital
BlackRock
BlackRock
Jones Financial Companies, L.L
Renaissance Technologies
Northern Trust
Bridgeway Capital Management
State Street Corporation
Susquehanna International
Simplex Trading
Creekmur Asset Management

View all funds holding Gain Therapeutics